Search Results 2471-2480 of 18276 for rheumatoid arthritis

  1. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... factor agents) within 2 weeks prior to the first dose of study treatment; any other anti-cancer therapy, whether investigational or approved, including but ...

  2. Cold hands - Mayo Clinic

    National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov/health-topics/scleroderma. Accessed Feb. 29, 2024. Varga J ...

  3. Publications - Katie N. Hunt, M.D. - Mayo Clinic

    ... factor: a case-control study. Breast Cancer Res. 2016 Apr 26; 18 (1):42. View PubMed; Conners AL, Jones KN, Hruska CB, Geske JR, Boughey JC, Rhodes DJ. Direct ...

  4. Shoulder pain - Mayo Clinic

    Firestein GS, et al. Shoulder pain. In: Firestein & Kelley's Textbook of Rheumatology. 11th ed. Elsevier; 2021. http://www.clinicalkey.com. Accessed June 12, ...

  5. Postoperative Infections Clinical Trials

    ... Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of ...

  6. Mayo Clinic-led study open for enrollment: Prehabilitation for patients receiving radiotherapy and surgery for soft tissue sarcoma

    One factor in customization is tumor location. Each participant will have weekly in-person meetings for prehabilitation during neoadjuvant radiotherapy ...

  7. RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

    * A clinical diagnosis of SLE, based on the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for ...

  8. Technical Reports - Department of Quantitative Health Sciences - Mayo Clinic Research

    Population attributable risk (PAR) is a function of time because both the prevalence of a risk factor and its effect on exposed individuals may change over ...

  9. Hematology - Clinical trials

    The purpose of this study is to learn about how platelets adhere to the blood von Willebrand factor and how known clinical mutations that result in bleeding ...

  10. Hematology - Clinical trials

    The purpose of this study is to learn about how platelets adhere to the blood von Willebrand factor and how known clinical mutations that result in bleeding ...